Stangeland; Eric
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stangeland; Eric.The latest application filed is for "bicyclic compounds useful as gpr120 modulators".
Company Profile
10.19.31
- Stangeland; Eric - Boston MA
- STANGELAND; Eric - Pacifica CA
- Stangeland; Eric - San Francisco CA
Patent Activity
| Patent | Date |
|---|---|
| Bicyclic Compounds Useful As Gpr120 Modulators App 20210347768 - Raimundo; Brian ; et al. | 2021-11-11 |
| Monocyclic Compounds Useful As Gpr120 Modulators App 20210101896 - Raimundo; Brian ; et al. | 2021-04-08 |
| Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20210024493 - HUGHES; Adam D. ; et al. | 2021-01-28 |
| Bicyclic compounds useful as GPR120 modulators Grant 10,865,201 - Raimundo , et al. December 15, 2 | 2020-12-15 |
| Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity Grant 10,836,744 - Hughes , et al. November 17, 2 | 2020-11-17 |
| Monocyclic compounds useful as GPR120 modulators Grant 10,800,773 - Raimundo , et al. October 13, 2 | 2020-10-13 |
| Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20200165223 - HUGHES; Adam D. ; et al. | 2020-05-28 |
| Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Grant 10,590,107 - Hughes , et al. | 2020-03-17 |
| Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20190300504 - HUGHES; Adam D. ; et al. | 2019-10-03 |
| Diamide compounds having muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activity Grant 10,358,433 - Hughes , et al. | 2019-07-23 |
| Bicyclic Compounds Useful As Gpr120 Modulators App 20190218208 - Raimundo; Brian ; et al. | 2019-07-18 |
| Monocyclic Compounds Useful As Gpr120 Modulators App 20190202821 - Raimundo; Brian ; et al. | 2019-07-04 |
| Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity App 20190047984 - HUGHES; Adam D. ; et al. | 2019-02-14 |
| 3-phenoxymethylpyrrolidine compounds Grant 9,227,933 - Stangeland , et al. January 5, 2 | 2016-01-05 |
| 3-phenoxymethylpyrrolidine Compounds App 20150126577 - Stangeland; Eric ; et al. | 2015-05-07 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20130178509 - Stangeland; Eric ; et al. | 2013-07-11 |
| Biphenyl Derivatives App 20130150404 - Mammen; Mathai ; et al. | 2013-06-13 |
| 3-phenoxymethylpyrrolidine compounds Grant 8,455,665 - Stangeland , et al. June 4, 2 | 2013-06-04 |
| Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,399,488 - Ji , et al. March 19, 2 | 2013-03-19 |
| 3-phenoxymethylpyrrolidine Compounds App 20120309985 - STANGELAND; Eric ; et al. | 2012-12-06 |
| 3-phenoxymethylpyrrolidine compounds Grant 8,273,786 - Stangeland , et al. September 25, 2 | 2012-09-25 |
| Biphenyl derivatives Grant 8,242,135 - Mammen , et al. August 14, 2 | 2012-08-14 |
| Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20120122850 - JI; Yu-Hua ; et al. | 2012-05-17 |
| Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,119,796 - Ji , et al. February 21, 2 | 2012-02-21 |
| Biphenyl Derivatives App 20110312994 - Mammen; Mathai ; et al. | 2011-12-22 |
| Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20110281851 - JI; Yu-Hua ; et al. | 2011-11-17 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20110275694 - Stangeland; Eric ; et al. | 2011-11-10 |
| 3-phenoxymethylpyrrolidine Compounds App 20110257243 - Stangeland; Eric ; et al. | 2011-10-20 |
| Biphenyl compounds useful as muscarinic receptor antagonists Grant 8,013,152 - Ji , et al. September 6, 2 | 2011-09-06 |
| Biphenyl derivatives Grant 7,879,879 - Mammen , et al. February 1, 2 | 2011-02-01 |
| 3-phenoxymethylpyrrolidine Compounds App 20110021597 - STANGELAND; Eric ; et al. | 2011-01-27 |
| 3-phenoxymethylpyrrolidine Compounds App 20110009465 - Stangeland; Eric ; et al. | 2011-01-13 |
| Biphenyl Compounds Useful As Muscarinic Receptor Antagonists App 20100197667 - JI; Yu-Hua ; et al. | 2010-08-05 |
| Biphenyl compounds useful as muscarinic receptor antagonists Grant 7,728,144 - Ji , et al. June 1, 2 | 2010-06-01 |
| 3-(phenoxyphenylmethyl)pyrrolidine Compounds App 20100022616 - Stangeland; Eric ; et al. | 2010-01-28 |
| Biphenyl derivatives Grant 7,514,558 - Mammen , et al. April 7, 2 | 2009-04-07 |
| Biphenyl derivatives App 20080015220 - Mammen; Mathai ; et al. | 2008-01-17 |
| Biphenyl derivatives App 20070276003 - Mammen; Mathai ; et al. | 2007-11-29 |
| Biphenyl derivatives App 20070208176 - Mammen; Mathai ; et al. | 2007-09-06 |
| Biphenyl derivatives App 20070088054 - Mammen; Mathai ; et al. | 2007-04-19 |
| Biphenyl compounds useful as muscarinic receptor antagonists App 20060281740 - Ji; Yu-Hua ; et al. | 2006-12-14 |
| Biphenyl derivatives Grant 7,141,671 - Mammen , et al. November 28, 2 | 2006-11-28 |
| Biphenyl derivatives App 20060223860 - Mammen; Mathai ; et al. | 2006-10-05 |
| Biphenyl derivatives App 20040167167 - Mammen, Mathai ; et al. | 2004-08-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 